| Product Name | MF | CAS | Details |
|---|
| Mirabegron | C21H24N4O2S | 223673-61-8 | Details |
| Acarbose tridecaacetate | C51H69NO31 | 117065-98-2 | Details |
| HSPE1 antibody | Details |
| 2-(1-Chloroethyl)pyrimidine hydrochloride | C6H8Cl2N2 | 2031258-69-0 | Details |
| 1-(Naphthalene-1-carbonyl)piperidine-4-carboxylic acid | C17H17NO3 | 147636-51-9 | Details |
| 2-Methylbenzoxazole | C8H7NO | 95-21-6 | Details |
| 2-Chloro-N-(2-methylpropyl)pyrimidin-4-amine | C8H12ClN3 | 1201176-19-3 | Details |
| MAP3K10 antibody | Details |
| 4-Bromoisophthalic acid | C8H5BrO4 | 6939-93-1 | Details |
| 4-[(4-Hydroxy-3,5-dimethoxyphenyl)methylidene]-1,2-dimethyl-4,5-dihydro-1H-imidazol-5-one | C14H16N2O4 | 1629243-34-0 | Details |
| GLP2R antibody | Details |
| 4-Chloro-N-(2-chlorophenyl)-3-nitrobenzene-1-sulfonamide | C12H8Cl2N2O4S | 26848-43-1 | Details |
| Goat anti Chicken IgY (H + L) | Details |
| N-Hexanoyl-D-glucosamine | C12H23NO6 | 19817-88-0 | Details |
| 6-Methanesulfonyl-6-azabicyclo[3.1.0]hexane | C6H11NO2S | 2060006-14-4 | Details |
| [(4-Chloro-1-methyl-1H-pyrrol-2-yl)methyl](methyl)amine | C7H11ClN2 | 1384427-60-4 | Details |
| Bacopaside N2 | C42H68O14 | 871706-75-1 | Details |
| 1-(4-Ethylphenyl)piperidin-4-one | C13H17NO | 1016690-06-4 | Details |
| TARS protein (His tag) | Details |
| 2,5-Bis[2-(N,N-diethylamino)-ethoxy]-1,4-dibromobenzene | C18H30Br2N2O2 | 233753-19-0 | Details |
| 5-Amino-1-(pyrimidin-2-yl)-1H-pyrazol-3-ol | C7H7N5O | 1291707-77-1 | Details |
| 3-[5-(Oxolan-2-yl)-1,2,4-oxadiazol-3-yl]phenol | C12H12N2O3 | 1152514-20-9 | Details |
| 1-Boc-4-bromomethylpiperidine | C11H20BrNO2 | 158407-04-6 | Details |
| Temelimab | 1393641-34-3 | Details |
| 1-[(2,3-Difluorophenyl)methyl]piperazine hydrochloride | C11H15ClF2N2 | 510725-56-1 | Details |
| LDV FITC | C69H81N11O17S | 1207610-07-8 | Details |
| PAR-4 (1-6) amide (mouse) | C33H46N8O7 | 245443-52-1 | Details |
| Diisopropylcarbonate | C7H14O3 | 6482-34-4 | Details |
| N-Methylazetidine-2-carboxamide hydrochloride | C5H11ClN2O | 1696683-26-7 | Details |
| (2S)-2-(3-Amino-2,2-dimethylpropanamido)-3-(4-hydroxyphenyl)propanoic acid hydrochloride | C14H20N2O4.ClH | 2378490-67-4 | Details |
| 1-[3-(Aminomethyl)pentan-3-yl]-4-chlorobenzene | C12H18ClN | 1183814-22-3 | Details |
| 4,4-Difluoro-N-methoxy-N-methylcyclohexanecarboxamide | C9H15F2NO2 | 917383-03-0 | Details |
| 5-Nitrosoquinolin-8-ol | C9H6N2O2 | 3565-26-2 | Details |
| 3-(4-Methoxy-2-methylphenyl)-1H-pyrazol-5-ylamine | C11H13N3O | 502132-58-3 | Details |
| 2,5-Thiazolylmethyl diacarbonate | C28H30N4O5S2 | 144142-33-6 | Details |
| 1-(2'-O-4-C-Methylene-b-D-ribofuranosyl)guanine | C11H13N5O5 | 207131-16-6 | Details |
| tert-Butyl N-[1-(4-oxooxan-3-yl)ethyl]carbamate | C12H21NO4 | 1692142-55-4 | Details |
| 9-(2'-Deoxy-5'-O-DMT-b-D-xylofuranosyl)adenine | Details |
| Tropaeolin O sodium salt | C12H11N2NaO5S | 547-57-9 | Details |
| all-cis-4,7,10,13,16-Docosapentaenoic acid | C22H34O2 | 25182-74-5 | Details |
| 1-Cyclopentylpropan-1-amine | C8H17N | 1178925-64-8 | Details |
| 2-[4-(Propane-2-sulfonyl)phenyl]acetic acid | C11H14O4S | 1105193-73-4 | Details |
| (3-Amino-3,4-dihydro-2H-1-benzopyran-3-yl)methanol hydrochloride | C10H14ClNO2 | 2044773-90-0 | Details |
| Methyl 2-(hydroxymethyl)-3,6-dihydro-2H-pyran-2-carboxylate | 2361634-99-1 | Details |
| 10-Deazaminopterin | C20H21N7O5 | 52454-37-2 | Details |
| LMO3 antibody | Details |
| 6-Methylazulene | C11H10 | 1654-52-0 | Details |
| JD 5037 | C27H27Cl2N5O3S | 1392116-14-1 | Details |
| 4-Phenoxybenzenesulfonamide | C12H11NO3S | 123045-62-5 | Details |
| KIF2A antibody | Details |
| (3S,4S)-4-Amino-3-hydroxy-6-methylheptanoic acid | C8H17NO3 | 49642-07-1 | Details |
| Methyl tricosanoate | C24H48O2 | 2433-97-8 | Details |
| 2-N-Chloroacetyl-2-deoxy-D-glucosamine | C8H14ClNO6 | 1334320-67-0 | Details |
| 5-Chloro-N-ethyl-1,3-benzothiazol-2-amine | C9H9ClN2S | 685124-12-3 | Details |
| 2-(7-Amino-4-methyl-2-oxo-2H-chromen-3-yl)acetic acid | C12H11NO4 | 106562-32-7 | Details |
| (2,5-Difluorophenyl)[3-(methylsulfanyl)phenyl]methanamine | C14H13F2NS | 1354953-05-1 | Details |
| C-Peptide 2 (rat) | C135H222N38O49 | 41594-08-5 | Details |
| 1-(1-{[(9H-Fluoren-9-yl)methoxy]carbonyl}piperidin-4-yl)-5-methyl-1H-pyrazole-4-carboxylic acid | C25H25N3O4 | 2137635-06-2 | Details |
| C5ORF4 Blocking Peptide | Details |
| 3H,4H,5H-Pyridazino[4,5-b]indol-4-one | C10H7N3O | 22814-13-7 | Details |
| 2-(1,5-Dimethyl-1H-1,3-benzodiazol-2-yl)ethan-1-amine dihydrochloride | C11H17Cl2N3 | 1305712-10-0 | Details |
| N4-Benzoyl-L-cytidine | C16H17N3O6 | 1018812-31-1 | Details |
| [Met(O)12]-ANP (Human, 1-28) | C127H205N45O39S3 | 91917-63-4 | Details |
| 2-(2,2,2-Trifluoroethanesulfonyl)acetic acid | C4H5F3O4S | 57008-25-0 | Details |
| COPS4 Blocking Peptide | Details |
| MRRF protein (His tag) | Details |
| 3-(Chloromethyl)-1-(2-fluoroethyl)-1H-pyrazole hydrochloride | 2193068-03-8 | Details |
| DGCR8 Blocking Peptide | Details |
| 2-[3-(4-Fluorophenyl)-1,2,4-oxadiazol-5-yl]-2,3-dihydro-1H-indole | C16H12FN3O | 1154346-82-3 | Details |
| methyl 6-amino-1H-indole-3-carboxylate | C10H10N2O2 | 1249763-34-5 | Details |
| 4-Ethoxy-N-ethylaniline | C10H15NO | 65570-13-0 | Details |
| 3-((3,5-bis(trifluoromethyl)phenyl)amino)-5-phenylcyclohex-2-en-1-one | C20H15F6NO | 946386-77-2 | Details |
| 1,3-Bis(2,6-diisopropylphenyl)imidazolidin-2-ylidene | C27H38N2 | 258278-28-3 | Details |
| Trilaciclib hydrochloride | C24H31ClN8O | 1977495-97-8 | Details |
| (3,3-Dimethoxy-1-methylcyclobutyl)methanamine hydrochloride | C8H18ClNO2 | 2140326-68-5 | Details |
| 2-Bromo-4-iodoanisole | C7H6BrIO | 182056-39-9 | Details |
| Methyl 2-amino-2-(3,4-dimethoxyphenyl)acetate | C11H15NO4 | 191998-16-0 | Details |
| rac-1-[(3R,4S)-4-Methoxyoxolan-3-yl]-1H-1,2,3-triazole-4-carboxylic acid | C8H11N3O4 | 1807891-04-8 | Details |
| CRP antibody (FITC) | Details |
| 2-(1-Chloro-ethyl)-thiazole | C5H6ClNS | 40982-31-8 | Details |
| Prop-2-yn-1-yl (2S)-2-amino-3-methylbutanoate hydrochloride | 2243501-31-5 | Details |
| H1FOO Blocking Peptide | Details |
| 2-(3-Hydroxyphenyl)acetohydrazide | C8H10N2O2 | 20277-01-4 | Details |
| TNF alpha antibody (biotin) | Details |
| N-[(4-fluorophenyl)methyl]-1-phenylcyclopentane-1-carboxamide | C19H20FNO | 845290-98-4 | Details |
| Termitomycamide E | C26H41NO2 | 1177258-62-6 | Details |
| 2-(Aminomethyl)-3H,4H,5H,7H,8H-pyrano[4,3-d]pyrimidin-4-one hydrochloride | C8H12ClN3O2 | 2094713-98-9 | Details |
| Zidapamide | C16H16ClN3O3S | 75820-08-5 | Details |
| (2E)-2-(Propan-2-yl)but-2-enedioic acid | C7H10O4 | 7596-39-6 | Details |
| Methyl 3-[(4-bromo-1H-pyrazol-1-yl)methyl]benzoate | C12H11BrN2O2 | 1005628-24-9 | Details |
| 4-(3-Amino-2-methylphenyl)-4,5-dihydro-1H-1,2,4-triazol-5-one | C9H10N4O | 1803585-72-9 | Details |
| 4-[5-Oxo-3-(trifluoromethyl)-4,5-dihydro-1H-pyrazol-1-yl]benzoic acid | C11H7F3N2O3 | 150649-14-2 | Details |
| UFSP2 antibody | Details |
| 2-Hydroxy-6,7-dimethoxyquinoxaline | C10H10N2O3 | 5739-98-0 | Details |
| 5-Chloro-N-methyl-1,3-benzothiazol-2-amine | C8H7ClN2S | 34551-17-2 | Details |
| (2,6-difluorophenyl)-N-(4,6-dimethylpyrimidin-2-yl)formamide | C13H11F2N3O | 712285-62-6 | Details |
| H-GLTVLPPLL^-OH | Details |
| PLD1 antibody | Details |
| GMPR2 Blocking Peptide | Details |
| Product Total： Product Page： | ||||
| 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 | ||||